RETRACTED: Synthesis and Biological Evaluation of Entecavir 4′-Ester Derivatives (Retracted article. See vol. 31, pg. 1078, 2015)

被引：3

作者：

Feng Deri ^{[1
]}

Liu Jiaan ^{[1
]}

Liang Shuang ^{[1
]}

Wang Yanyan ^{[1
]}

Xu Youjun ^{[1
]}

机构：

[1] Shenyang Pharmaceut Univ, Sch Pharmaceut Engn, Shenyang 110016, Peoples R China

来源：

CHEMICAL RESEARCH IN CHINESE UNIVERSITIES | 2014年 / 30卷 / 05期

基金：

中国国家自然科学基金;

关键词：

Entecavir; Anti-HBV activity; Intestinal membrane permeability; HEPATITIS-B-VIRUS; PHARMACOKINETICS; INFECTION; PRODRUG; POTENT; ACID; LAMIVUDINE; TRIAL; DRUG;

D O I：

10.1007/s40242-014-4183-y

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Entecavir can significantly inhibit the replication of HBV-DNA, reduce the HBV-DNA level in blood serum. But suffering from low oral bioavailability, entecavir has low intestinal membrane permeability and poor metabolic stability. In this study, 12 different derivatives of entecavir 4'-ester were regioselectively synthesized and their apical-to-basolateral permeabilities across Caco-2 cells and HBV-DNA inhibitory efficacies were evaluated. Most of the compounds showed high permeabilities across Caco-2 cells compared with entecavir, compounds 5b and 5e also exhibited comparable anti-BBV activities with that of entecavir, especially.

引用

页码：749 / 754

页数：6

共 26 条

[1] Direct evidence for peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug, valacyclovir [J].

Balimane, PV ;

Tamai, I ;

Guo, AL ;

Nakanishi, T ;

Kitada, H ;

Leibach, FH ;

Tsuji, A ;

Sinko, PJ .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 250 (02) :246-251

[2] 4-Benzyl- and 4-benzoyl-3-dimethylaminopyridin-2(1H)-ones, a new family of potent anti-HIV agents:: Optimization and in vitro evaluation against clinically important HIV mutant strains [J].

Benjahad, A ;

Courté, K ;

Guillemont, J ;

Mabire, D ;

Coupa, S ;

Poncelet, A ;

Csoka, I ;

Andries, K ;

Pauwels, R ;

de Béthune, MP ;

Monneret, C ;

Bisagni, E ;

Nguyen, CH ;

Grierson, DS .

JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (22) :5501-5514

[3] Dipeptides as effective prodrugs of the unnatural amino acid (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740), a selective group II metabotropic glutamate receptor agonist [J].

Bueno, AB ;

Collado, I ;

de Dios, A ;

Domínguez, C ;

Martín, JA ;

Martín, LM ;

Martínez-Grau, MA ;

Montero, C ;

Pedregal, C ;

Catlow, J ;

Coffey, DS ;

Clay, MP ;

Dantzig, AH ;

Lindstrom, T ;

Monn, JA ;

Jiang, HY ;

Schoepp, DD ;

Stratford, RE ;

Tabas, LB ;

Tizzano, JP ;

Wright, RA ;

Herin, MF .

JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (16) :5305-5320

[4] Entecavir, FTC, L-FMAU, LdT and others [J].

Buti, M ;

Esteban, R .

JOURNAL OF HEPATOLOGY, 2003, 39 :S139-S142

[5] Synthesis and antiviral activity of oxaselenolane nucleosides [J].

Chu, CK ;

Ma, L ;

Olgen, S ;

Pierra, C ;

Du, JF ;

Gumina, G ;

Gullen, E ;

Cheng, YC ;

Schinazi, RF .

JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (21) :3906-3912

[6] Antiviral efficacy and pharmacokinetics of oral adefovir dipivoxil in chronically woodchuck hepatitis virus-infected woodchucks [J].

Cullen, JM ;

Ll, DH ;

Brown, C ;

Eisenberg, EJ ;

Cundy, KC ;

Wolfe, J ;

Toole, J ;

Gibbs, C .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (10) :2740-2745

[7]

Daniel G., 2013, CLIN SCI, V124, P77

[8] A PRELIMINARY TRIAL OF LAMIVUDINE FOR CHRONIC HEPATITIS-B INFECTION [J].

DIENSTAG, JL ;

PERRILLO, RP ;

SCHIFF, ER ;

BARTHOLOMEW, M ;

VICARY, C ;

RUBIN, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (25) :1657-1661

[9] Early kinetics of innate and adaptive immune responses during hepatitis B virus infection [J].

Fisicaro, P. ;

Valdatta, C. ;

Boni, C. ;

Massari, M. ;

Mori, C. ;

Zerbini, A. ;

Orlandini, A. ;

Sacchelli, L. ;

Missale, G. ;

Ferrari, C. .

GUT, 2009, 58 (07) :974-982

[10]

Gregory Y., 1999, ANTIMICROB AGENTS CH, V43, P190

← 1 2 3 →